DDInter1149 DDInter1180
Mepenzolate is a post-ganglionic parasympathetic inhibitor. It decreases gastric acid and pepsin secretion and suppresses spontaneous contractions of the colon. Mepenzolate diminishes gastric acid and pepsin secretion. Mepenzolate also suppresses spontaneous contractions of the colon. Pharmacologically, it is a post-ganglionic parasympathetic inhibitor. It has not been shown to be effective in contributing to the healing of peptic ulcer, decreasing the rate of recurrence, or preventing complications.
Methscopolamine is a quaternary ammonium derivative of scopolamine and antagonist at muscarininc (mACh) receptors. Methscopolamine bromide is the most common form of the active ingredient in oral pharmaceutical products. The oral tablets are used as an adjunct therapy for the treatment of peptic ulcer and is shown to be effective in decreasing the rate of recurrence of peptic ulcers as well as preventing complications.
Mepenzolate {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Dextropropoxyphene
Mepenzolate {u} (Compound) resembles {v} (Compound) Fexofenadine
Mepenzolate {u} (Compound) resembles {v} (Compound) Diphemanil Methylsulfate
Mepenzolate {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Aclidinium
Mepenzolate {u} (Compound) binds {v} (Gene) CHRM1
Mepenzolate {u} (Compound) upregulates {v} (Gene) SGCB
Mepenzolate {u} (Compound) is included by {v} (Pharmacologic Class) Cholinergic Antagonists
Mepenzolate {u} (Compound) downregulates {v} (Gene) DLD
Mepenzolate {u} (Compound) causes {v} (Side Effect) Bloated feeling
Mepenzolate {u} may cause a minor interaction that can limit clinical effects when taken with {v} Indapamide
Mepenzolate may cause a moderate interaction that could exacerbate diseases when taken with Dextropropoxyphene
Mepenzolate (Compound) resembles Fexofenadine (Compound)
Mepenzolate (Compound) resembles Diphemanil Methylsulfate (Compound)
Mepenzolate may cause a moderate interaction that could exacerbate diseases when taken with Aclidinium
Mepenzolate (Compound) binds CHRM1 (Gene)
Mepenzolate (Compound) upregulates SGCB (Gene)
Mepenzolate (Compound) is included by Cholinergic Antagonists (Pharmacologic Class)
Mepenzolate (Compound) downregulates DLD (Gene)
Mepenzolate (Compound) causes Bloated feeling (Side Effect)
Mepenzolate may cause a minor interaction that can limit clinical effects when taken with Indapamide